Medications are the first-line treatment for atrial fibrillation, or A-fib. When they begin to fail, one option is ablation.

Abbott (NYSE: ABT) today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volt™ PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin ...

The Punjab government has decided to introduce state-of-the-art intravascular surgery techniques for the treatment of heart ...

Sarawak has reached a new milestone in advanced cardiac care with the successful completion of the first EPi-Sense hybrid ...

Columbus Regional Health Electrophysiology team completes 500th ablation case for treating irregular heartbeats ...

Thursday, March 1, 2018, 11pm, I lay in bed trying not to panic. My heart was racing so fast I could not find my pulse. It was also erratic, jumping around like ...

SRM Global Hospitals successfully treated an 80-year-old patient with irregular heart rhythm using advanced TactiFlex catheter ablation technology.

Other hot topics included new data on LAAO and conduction-system pacing, plus the go-ahead for ablation in ASCs.

Abbott today announced the U.S. Food and Drug Administration (FDA) has approved the company's Volttm PFA System to treat patients battling atrial fibrillation (AFib). Abbott will soon begin commercial ...

LAHORE: The Punjab government has decided to introduce state-of-the-art intravascular surgery techniques for the treatment of ...

Abbott has announced the company has received approval from the U.S. Food and Drug Administration (FDA) for its Volt PFA ...

Pulse Biosciences PLSE recently announced that the FDA has granted Investigational Device Exemption (“IDE”) approval to ...